Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Kraken COVID variant UK: All we know about the new XBB.1.5 strain
Jan 01, 2024Lexington Executive Admits Selling Counterfeit N95 Masks During Pandemic: Facing Up to Three Years in Prison
Jun 11, 2023N95 vs. KN95 Masks
Jun 10, 2023Best NIOSH
Jun 08, 2023The real bacterial filtration efficiency to evaluate the effective protection of facemasks used for the prevention of respiratory diseases
Jun 25, 2023FDA In Brief: FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems as Access to N95s Increases Nationwide
Jun 02, 2023FDA in Brief
The following quote is attributed to Suzanne Schwartz, M.D., M.B.A., director of the Office of Strategic Partnerships and Technology Innovation in the FDA's Center for Devices and Radiological Health
Español
"Throughout the pandemic, the FDA has worked closely with our federal partners at the Centers for Disease Control and Prevention's National Institute for Occupational Safety and Health (NIOSH), the Occupational Safety and Health Administration (OSHA) and with manufacturers to protect our front-line workers by facilitating access to the medical supplies they require. As a result of these efforts, our country is now better positioned to provide health care workers with access to NIOSH-approved N95s rather than using non-NIOSH-approved respirators or reusing decontaminated disposable respirators.
Early in the public health emergency, there was a need to issue emergency use authorizations (EUAs) for non-NIOSH-approved respirators as well as decontamination and bioburden reduction systems to disinfect disposable respirators. Today, those conditions no longer exist. Our national supply of NIOSH-approved N95s is more accessible to our health care workers every day.
Today, the FDA is taking additional action by announcing the revocation of EUAs for imported, non-NIOSH-approved respirators as well as decontamination and bioburden reduction systems because of an increase in domestically-manufactured NIOSH-approved N95s available throughout the country. As access to domestic supply of disposable respirators continues to significantly improve, health care organizations should transition away from crisis capacity conservation strategies that were implemented at the onset of the pandemic."
###
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
06/30/2021
More Press Announcements